CM
HZNP
Castleark Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-16,495
| Closed | -$1.32M | – | 352 |
|
2022
Q2 | $1.32M | Sell |
16,495
-14,265
| -46% | -$1.14M | 0.07% | 180 |
|
2022
Q1 | $3.24M | Sell |
30,760
-2,630
| -8% | -$277K | 0.14% | 153 |
|
2021
Q4 | $3.6M | Sell |
33,390
-1,740
| -5% | -$187K | 0.13% | 157 |
|
2021
Q3 | $3.85M | Sell |
35,130
-5,280
| -13% | -$578K | 0.15% | 150 |
|
2021
Q2 | $3.78M | Buy |
40,410
+105
| +0.3% | +$9.83K | 0.13% | 157 |
|
2021
Q1 | $3.71M | Sell |
40,305
-1,840
| -4% | -$169K | 0.13% | 156 |
|
2020
Q4 | $3.08M | Sell |
42,145
-214,440
| -84% | -$15.7M | 0.12% | 160 |
|
2020
Q3 | $19.9M | Sell |
256,585
-92,000
| -26% | -$7.15M | 0.78% | 34 |
|
2020
Q2 | $19.4M | Buy |
348,585
+33,030
| +10% | +$1.84M | 0.84% | 31 |
|
2020
Q1 | $9.35M | Buy |
+315,555
| New | +$9.35M | 0.55% | 50 |
|
2019
Q3 | – | Sell |
-362,980
| Closed | -$8.73M | – | 416 |
|
2019
Q2 | $8.73M | Buy |
362,980
+7,442
| +2% | +$179K | 0.34% | 101 |
|
2019
Q1 | $9.4M | Buy |
355,538
+62,578
| +21% | +$1.65M | 0.35% | 92 |
|
2018
Q4 | $5.72M | Buy |
+292,960
| New | +$5.72M | 0.24% | 129 |
|
2016
Q4 | – | Sell |
-478,965
| Closed | -$8.68M | – | 435 |
|
2016
Q3 | $8.68M | Buy |
+478,965
| New | +$8.68M | 0.26% | 118 |
|
2015
Q4 | – | Sell |
-456,218
| Closed | -$9.04M | – | 437 |
|
2015
Q3 | $9.04M | Sell |
456,218
-154,382
| -25% | -$3.06M | 0.29% | 93 |
|
2015
Q2 | $21.2M | Sell |
610,600
-908,450
| -60% | -$31.6M | 0.57% | 43 |
|
2015
Q1 | $39.5M | Buy |
1,519,050
+917,550
| +153% | +$23.8M | 0.95% | 27 |
|
2014
Q4 | $7.75M | Sell |
601,500
-109,428
| -15% | -$1.41M | 0.2% | 136 |
|
2014
Q3 | $10.7M | Buy |
710,928
+43,425
| +7% | +$657K | 0.31% | 55 |
|
2014
Q2 | $10.6M | Sell |
667,503
-43,425
| -6% | -$687K | 0.29% | 60 |
|
2014
Q1 | $10.7M | Buy |
710,928
+210,670
| +42% | +$3.19M | 0.31% | 55 |
|
2013
Q4 | $3.81M | Buy |
+500,258
| New | +$3.81M | 0.11% | 171 |
|